ACET Adicet Bio, Inc.
Price Chart
Executive Summary
OrbiMed Israel GP Ltd., the general partner of OrbiMed Israel Partners Limited Partnership, filed a Form 144 to notify intent to sell up to 64,242 shares of Adicet Bio, Inc. (ACET) common stock. The filing is a routine notice of potential sale by an institutional holder and does not confirm that the sale will occur.
Actionable Insight
Monitor for actual sales via future Form 4 or Form 144 filings; this notice alone is not a sale and is typical for institutional holders managing positions. Given the small size relative to market cap, significant price impact is unlikely unless part of a broader exit pattern.
Key Facts
- Reporting entity: OrbiMed Israel GP Ltd., acting as general partner for OrbiMed Israel Partners Limited Partnership
- Number of shares proposed for sale: 64,242
- Security type: Common stock
- Filing date: April 7, 2026
- Method of sale: Not specified in filing
- Relationship: Institutional shareholder, not an officer or director of ACET
Financial Impact
Approximately $2.6 million based on current market price ($41.31 per share), representing a small fraction of ACET's $66M market cap
Risk Factors
- Potential downward pressure on stock if sale is executed near-term, especially given ACET's low market cap
- Perception of reduced confidence by a major institutional holder, though OrbiMed remains invested
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000947871-26-000413 |
| Document: 0000947871-26-000413-index.html | 0000947871-26-000413 |
| Document: 0000947871-26-000413.txt | 0000947871-26-000413 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 20, 2026
20d ago
|
10-K/A
| $7.89 $9.31 | ▲ +18.00% | ▲ +16.15% | $7.22 (−8.49%) |
|
May 13, 2026
27d ago
|
8-K
| $8.41 $7.89 | ▼ −6.18% | ▼ −5.47% | $7.22 (−14.15%) |
|
Apr 9, 2026
8w ago
|
144
| $6.86 $8.05 | ▲ +17.35% | ▲ +14.16% | $7.22 (+5.25%) |
|
Apr 8, 2026
9w ago
|
144
| $6.55 $7.92 | ▲ +20.92% | ▲ +17.40% | $7.22 (+10.23%) |
|
Mar 24, 2026
11w ago
|
EFFECT
| $6.69 $6.81 | ▲ +1.79% | ▲ +2.22% | $7.22 (+7.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access